» Articles » PMID: 16646800

BayesMendel: an R Environment for Mendelian Risk Prediction

Overview
Date 2006 May 2
PMID 16646800
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Several important syndromes are caused by deleterious germline mutations of individual genes. In both clinical and research applications it is useful to evaluate the probability that an individual carries an inherited genetic variant of these genes, and to predict the risk of disease for that individual, using information on his/her family history. Mendelian risk prediction models accomplish these goals by integrating Mendelian principles and state-of-the-art statistical models to describe phenotype/genotype relationships. Here we introduce an R library called BayesMendel that allows implementation of Mendelian models in research and counseling settings. BayesMendel is implemented in an object-oriented structure in the language R and distributed freely as an open source library. In its first release, it includes two major cancer syndromes: the breast-ovarian cancer syndrome and the hereditary non-polyposis colorectal cancer syndrome, along with up-to-date estimates of penetrance and prevalence for the corresponding genes. Input genetic parameters can be easily modified by users. BayesMendel can also serve as a generic tool for genetic epidemiologists to flexibly implement their own Mendelian models for novel syndromes and local subpopulations, without reprogramming complex statistical analyses and prediction tools.

Citing Articles

Hereditary Cancer Genetic Testing: 30 Years of Impact on Cancer Care.

Flores K Dela J Public Health. 2024; 10(3):16-20.

PMID: 39211401 PMC: 11356586. DOI: 10.32481/djph.2024.08.06.


Identifying somatic fingerprints of cancers defined by germline and environmental risk factors.

Chakraborty S, Guan Z, Kostrzewa C, Shen R, Begg C Genet Epidemiol. 2024; 48(8):455-467.

PMID: 38686586 PMC: 11522022. DOI: 10.1002/gepi.22565.


Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data.

Nguyen N, Dodd-Eaton E, Corredor J, Woodman-Ross J, Green S, Gutierrez A J Clin Oncol. 2024; 42(18):2186-2195.

PMID: 38569124 PMC: 11191065. DOI: 10.1200/JCO.23.01926.


PREDICTION OF HEREDITARY CANCERS USING NEURAL NETWORKS.

Guan B, Parmigiani G, Braun D, Trippa L Ann Appl Stat. 2023; 16(1):495-520.

PMID: 37873507 PMC: 10593124. DOI: 10.1214/21-aoas1510.


Combining Breast Cancer Risk Prediction Models.

Guan Z, Huang T, McCarthy A, Hughes K, Semine A, Uno H Cancers (Basel). 2023; 15(4).

PMID: 36831433 PMC: 9953824. DOI: 10.3390/cancers15041090.


References
1.
Jimenez-Sanchez G, Childs B, Valle D . Human disease genes. Nature. 2001; 409(6822):853-5. DOI: 10.1038/35057050. View

2.
Offit K, Brown K . Quantitating familial cancer risk: a resource for clinical oncologists. J Clin Oncol. 1994; 12(8):1724-36. DOI: 10.1200/JCO.1994.12.8.1724. View

3.
Lin K, Shashidharan M, Thorson A, Ternent C, Blatchford G, Christensen M . Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg. 1998; 2(1):67-71. DOI: 10.1016/s1091-255x(98)80105-4. View

4.
Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M . The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997; 336(20):1401-8. DOI: 10.1056/NEJM199705153362001. View

5.
Newman B, Austin M, Lee M, King M . Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci U S A. 1988; 85(9):3044-8. PMC: 280139. DOI: 10.1073/pnas.85.9.3044. View